Recommend to a friend

Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease

Watch coverage from the CHEST 2019 Annual Meeting for information regarding Pirfenidone in patients with unclassifiable interstitial lung disease. Click here!

The France Foundation

A ACCME Accredited provider.

10 Vista Drive, Old Lyme, CT USA

Friend's Name :
Friend's email :
You may provide a message here that will be included in the emailed recommendation. (2000 Character Max) Characters written:
Your comment